English Español Français Русский Home About Partners Grant Portfolio Media Center Library Blog Home > Library > Publications >Turning the Tide Against HIV and Tuberculosis Global Fund Investment Guidance for Eastern Europe and Central Asia Library Publications Annual Reports Progress Reports Other Reports Governance and Core Documents Operational Policies, Guidelines and Tools Integrated Evaluations Turning the Tide Against HIV and Tuberculosis 14 August 2014 Global Fund Investment Guidance for Eastern Europe and Central Asia The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics. Guidance download [ PDF - 1 MBРусский ] Framework download [ PDF - 481 KB ] Share this page Facebook Twitter StumbleUpon E-Mail Link Key Documents Governance and Core Documents Operational Policies, Guidelines and Tools Board Decisions Publications Annual Reports Progress Reports Portfolio Downloads Pledges and Contributions (XLSX 488 KB) Other Sections Country Coordinating Mechanisms Local Fund Agents Monitoring and Evaluation Procurement and Supply Management Office of the Inspector General Business Opportunities Price & Quality Reporting (PQR) Employment Stay Connected RSS Facebook Twitter News Flash Contact | Report Fraud and Abuse | Legal | RSS | Sitemap © 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria

English Español Français Русский Home About Partners Grant Portfolio Media Center Library Blog Home >Market Dynamics Advisory Group (MDAG) Market Dynamics Advisory Group (MDAG) Market Dynamics Advisory Group (MDAG) The Market Dynamics Advisory Group (MDAG) advises the Global Fund on policies and initiatives to improve its ability to shape markets of key health products. Its purpose is to ensure that the Global Fund’s buying power is leveraged to advance the development and manufacture of appropriate health products to combat the three diseases, taking into consideration price, quality, availability, and design. MDAG Terms of Reference download [ PDF - 110 KBFrançais ] This advisory body assumes the strategic and operational oversight roles of the former Market Dynamics and Commodities Ad-Hoc Committee (“MDC”) and the Affordable Medicines Facility-malaria Ad-hoc Committee (“AMFm”). The MDAG reports to the Board through the Strategy, Investment and Impact Committee (SIIC) to enable alignment with the overall strategic direction of the Global Fund. It will ensure that the Board continues to receive high quality strategic advice on both market initiatives relevant to the Global Fund’s mandate, and innovative mechanisms that target improved access and impact at country level. Stay Connected RSS Facebook Twitter News Flash Contact | Report Fraud and Abuse | Legal | RSS | Sitemap © 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria